Cas:36701-89-0 2-[3-(Trifluoromethyl)phenoxy]nicotinic acid manufacturer & supplier

We serve Chemical Name:2-[3-(Trifluoromethyl)phenoxy]nicotinic acid CAS:36701-89-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-[3-(Trifluoromethyl)phenoxy]nicotinic acid

Chemical Name:2-[3-(Trifluoromethyl)phenoxy]nicotinic acid
CAS.NO:36701-89-0
Synonyms:2-(3-(trifluoromethyl)phenoxy)-3-pyridinecarboxylicacid;2-(3-trifluoromethyl-phenoxy)-nicotinic acid;2-(3-(trifluoromethyl)phenoxy)-3-pyridinecarboxylicaci
Molecular Formula:C13H8F3NO3
Molecular Weight:283.20300
HS Code:2933399090

Physical and Chemical Properties:
Melting point:156-159ºC
Boiling point:366ºC at 760mmHg
Density:1.421g/cm3
Index of Refraction:1.541
PSA:59.42000
Exact Mass:283.04600
LogP:3.59090

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(3-(trifluoromethyl)phenoxy)-3-pyridinecarboxylicacid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(3-(trifluoromethyl)phenoxy)-3-pyridinecarboxylicaci physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(3-trifluoromethyl-phenoxy)-nicotinic acid Use and application,2-(3-(trifluoromethyl)phenoxy)-3-pyridinecarboxylicacid technical grade,usp/ep/jp grade.


Related News: AZ’s chief financial officer and incoming Alexion head Marc Dunoyer acknowledged that the reimbursement infrastructure for rare disease drugs in China isn’t as advanced as it is in many developed economies. The rare disease market in China is still small, but there’s a growing recognition of its importance from authorities, he added. methyl 5-((2-acetamidoethyl)carbamoyl)-3-(4-fluorobenzyl)-8-hydroxyquinoline-7-carboxylate manufacturers After examining all the evidence, it was clear that more plausible explanations for the AML cases included the conditioning treatment the patients received to clear out bone marrow cells and the higher risk of blood cancer in people with sickle cell disease. 4-hydroxy-1-N,3-N-bis(4-methylphenyl)benzene-1,3-dicarboxamide suppliers Here’s how Biogen did during the three months ended June 30 compared with what Wall Street expected, according to average estimates compiled by Refinitiv. 7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carbonitrile vendor & factory.